Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 360

1.

Putative biomarkers of vedolizumab resistance and underlying inflammatory pathways involved in IBD.

Soendergaard C, Seidelin JB, Steenholdt C, Nielsen OH.

BMJ Open Gastroenterol. 2018 May 31;5(1):e000208. doi: 10.1136/bmjgast-2018-000208. eCollection 2018.

2.

Characterization of the enhancer and promoter landscape of inflammatory bowel disease from human colon biopsies.

Boyd M, Thodberg M, Vitezic M, Bornholdt J, Vitting-Seerup K, Chen Y, Coskun M, Li Y, Lo BZS, Klausen P, Jan Schweiger P, Pedersen AG, Rapin N, Skovgaard K, Dahlgaard K, Andersson R, Terkelsen TB, Lilje B, Troelsen JT, Petersen AM, Jensen KB, Gögenur I, Thielsen P, Seidelin JB, Nielsen OH, Bjerrum JT, Sandelin A.

Nat Commun. 2018 Apr 25;9(1):1661. doi: 10.1038/s41467-018-03766-z.

3.

Role of Vitamin D in the Natural History of Inflammatory Bowel Disease.

Nielsen OH, Rejnmark L, Moss AC.

J Crohns Colitis. 2018 May 25;12(6):742-752. doi: 10.1093/ecco-jcc/jjy025.

PMID:
29529167
4.

Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicine.

Christensen R, Heitmann BL, Andersen KW, Nielsen OH, Sørensen SB, Jawhara M, Bygum A, Hvid L, Grauslund J, Wied J, Glerup H, Fredberg U, Villadsen JA, Kjær SG, Fallingborg J, Moghadd SAGR, Knudsen T, Brodersen J, Frøjk J, Dahlerup JF, Bojesen AB, Sorensen GL, Thiel S, Færgeman NJ, Brandslund I, Bennike TB, Stensballe A, Schmidt EB, Franke A, Ellinghaus D, Rosenstiel P, Raes J, Boye M, Werner L, Nielsen CL, Munk HL, Nexøe AB, Ellingsen T, Holmskov U, Kjeldsen J, Andersen V.

BMJ Open. 2018 Feb 8;8(2):e018166. doi: 10.1136/bmjopen-2017-018166.

5.

Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease.

Nielsen OH, Soendergaard C, Vikner ME, Weiss G.

Nutrients. 2018 Jan 13;10(1). pii: E82. doi: 10.3390/nu10010082. Review.

6.

Relation between NOD2 genotype and changes in innate signaling in Crohn's disease on mRNA and miRNA levels.

Chen Y, Salem M, Boyd M, Bornholdt J, Li Y, Coskun M, Seidelin JB, Sandelin A, Nielsen OH.

NPJ Genom Med. 2017 Feb 8;2:3. doi: 10.1038/s41525-016-0001-4. eCollection 2017.

7.

YAP/TAZ-Dependent Reprogramming of Colonic Epithelium Links ECM Remodeling to Tissue Regeneration.

Yui S, Azzolin L, Maimets M, Pedersen MT, Fordham RP, Hansen SL, Larsen HL, Guiu J, Alves MRP, Rundsten CF, Johansen JV, Li Y, Madsen CD, Nakamura T, Watanabe M, Nielsen OH, Schweiger PJ, Piccolo S, Jensen KB.

Cell Stem Cell. 2018 Jan 4;22(1):35-49.e7. doi: 10.1016/j.stem.2017.11.001. Epub 2017 Dec 14.

8.

Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease.

Bjerrum JT, Steenholdt C, Ainsworth M, Nielsen OH, Reed MA, Atkins K, Günther UL, Hao F, Wang Y.

BMC Med. 2017 Oct 16;15(1):184. doi: 10.1186/s12916-017-0949-7.

9.

Characterization of Growth Hormone Resistance in Experimental and Ulcerative Colitis.

Soendergaard C, Kvist PH, Thygesen P, Reslow M, Nielsen OH, Kopchick JJ, Holm TL.

Int J Mol Sci. 2017 Sep 23;18(10). pii: E2046. doi: 10.3390/ijms18102046.

10.

Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.

Sørensen JØ, Nielsen OH, Andersson M, Ainsworth MA, Ytting H, Bélard E, Jess T.

Liver Int. 2018 Mar;38(3):532-541. doi: 10.1111/liv.13548. Epub 2017 Sep 5.

PMID:
28796371
11.

Impact of feedback and monitoring on colonoscopy withdrawal times and polyp detection rates.

Nielsen AB, Nielsen OH, Hendel J.

BMJ Open Gastroenterol. 2017 Jun 1;4(1):e000142. doi: 10.1136/bmjgast-2017-000142. eCollection 2017.

12.

Inflammatory Bowel Disease and Small Bowel Cancer Risk, Clinical Characteristics, and Histopathology: A Population-Based Study.

Bojesen RD, Riis LB, Høgdall E, Nielsen OH, Jess T.

Clin Gastroenterol Hepatol. 2017 Dec;15(12):1900-1907.e2. doi: 10.1016/j.cgh.2017.06.051. Epub 2017 Jul 8.

PMID:
28694132
13.

Intestinal barrier integrity and inflammatory bowel disease: Stem cell-based approaches to regenerate the barrier.

Holmberg FEO, Pedersen J, Jørgensen P, Soendergaard C, Jensen KB, Nielsen OH.

J Tissue Eng Regen Med. 2018 Apr;12(4):923-935. doi: 10.1002/term.2506. Epub 2017 Oct 19. Review.

PMID:
28636192
14.

A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised Medicine.

Andersen V, Holmskov U, Sørensen SB, Jawhara M, Andersen KW, Bygum A, Hvid L, Grauslund J, Wied J, Glerup H, Fredberg U, Villadsen JA, Kjær SG, Fallingborg J, Moghadd SAGR, Knudsen T, Brodersen J, Frøjk J, Dahlerup JF, Nielsen OH, Christensen R, Bojesen AB, Sorensen GL, Thiel S, Færgeman NJ, Brandslund I, Stensballe A, Schmidt EB, Franke A, Ellinghaus D, Rosenstiel P, Raes J, Heitmann B, Boye M, Nielsen CL, Werner L, Kjeldsen J, Ellingsen T.

Nutrients. 2017 May 15;9(5). pii: E499. doi: 10.3390/nu9050499.

15.

Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease.

Holmberg FE, Seidelin JB, Yin X, Mead BE, Tong Z, Li Y, Karp JM, Nielsen OH.

EMBO Mol Med. 2017 May;9(5):558-570. doi: 10.15252/emmm.201607260. Review.

16.

Sphingosine-1-Phosphate Signaling in Inflammatory Bowel Disease.

Nielsen OH, Li Y, Johansson-Lindbom B, Coskun M.

Trends Mol Med. 2017 Apr;23(4):362-374. doi: 10.1016/j.molmed.2017.02.002. Epub 2017 Mar 8. Review.

PMID:
28283249
17.

Novel Targeted Therapies for Inflammatory Bowel Disease.

Coskun M, Vermeire S, Nielsen OH.

Trends Pharmacol Sci. 2017 Feb;38(2):127-142. doi: 10.1016/j.tips.2016.10.014. Epub 2016 Dec 1. Review.

PMID:
27916280
18.

An open prospective study evaluating efficacy and safety of a new medical device for rectal application of activated carbon in the treatment of chronic, uncomplicated perianal fistulas.

Zawadzki A, Johnson LB, Bohe M, Johansson C, Ekelund M, Nielsen OH.

Int J Colorectal Dis. 2017 Apr;32(4):509-512. doi: 10.1007/s00384-016-2726-z. Epub 2016 Nov 23.

19.

How genetic testing can lead to targeted management of XIAP deficiency-related inflammatory bowel disease.

Nielsen OH, LaCasse EC.

Genet Med. 2017 Feb;19(2):133-143. doi: 10.1038/gim.2016.82. Epub 2016 Jul 14. Review.

PMID:
27416006
20.

Regulation of Laminin γ2 Expression by CDX2 in Colonic Epithelial Cells Is Impaired During Active Inflammation.

Coskun M, Soendergaard C, Joergensen S, Dahlgaard K, Riis LB, Nielsen OH, Sandelin A, Troelsen JT.

J Cell Biochem. 2017 Feb;118(2):298-307. doi: 10.1002/jcb.25636. Epub 2016 Jun 29.

PMID:
27333824

Supplemental Content

Loading ...
Support Center